Home » Topics » Regulatory » Patents

Patents
RSS

Nicotinic acetylcholine receptor agonists emerge from Sumitomo R&D

Jan. 28, 1999

Yoshitomi's new immunosuppressive agents for arthritis, autoimmune diseases and transplant rejection

Jan. 27, 1999

Ligand inhibitors of CRF/CRF-binding protein complex reported by Lilly

Jan. 27, 1999

Neuronal Ca2+ channel-blocking peptides in development at Mitsubishi

Jan. 27, 1999

Canadian pharmaceutical and academic research team discovers new benzoporphyrins for PDT

Jan. 27, 1999

Potent ACAT inhibitors for lipid disorders from Sankyo

Jan. 27, 1999

New amidines synthesized at Astra are selective inhibitors of nNOS

Jan. 27, 1999

Chugai patents 2,3-dihydrobenzofurans with cytoprotective effects

Jan. 27, 1999

More 5-HT4 receptor ligands in development at Synthelabo

Jan. 26, 1999

Subunit-selective GABA-A receptor ligands for anxiety, convulsions reported by MS&D

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...